NO20006694L - Nye antihistamin-piperidinderivater og mellomprodukter for fremstilling derav - Google Patents

Nye antihistamin-piperidinderivater og mellomprodukter for fremstilling derav

Info

Publication number
NO20006694L
NO20006694L NO20006694A NO20006694A NO20006694L NO 20006694 L NO20006694 L NO 20006694L NO 20006694 A NO20006694 A NO 20006694A NO 20006694 A NO20006694 A NO 20006694A NO 20006694 L NO20006694 L NO 20006694L
Authority
NO
Norway
Prior art keywords
intermediates
preparation
piperidine derivatives
antihistamine
new
Prior art date
Application number
NO20006694A
Other languages
English (en)
Other versions
NO319534B1 (no
NO20006694D0 (no
Inventor
Timothy A Ayers
Paul Wayne Brown
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22328222&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20006694(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of NO20006694D0 publication Critical patent/NO20006694D0/no
Publication of NO20006694L publication Critical patent/NO20006694L/no
Publication of NO319534B1 publication Critical patent/NO319534B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/72—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
    • C07C235/76—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C07C235/78—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/90—Carboxylic acid amides having nitrogen atoms of carboxamide groups further acylated
    • C07C233/91—Carboxylic acid amides having nitrogen atoms of carboxamide groups further acylated with carbon atoms of the carboxamide groups bound to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20006694A 1998-07-02 2000-12-29 Mellomprodukt og fremgangsmater for fremstilling av antihistaminiske piperidinderivater og anvendelse derav for fremstilling av et medikament. NO319534B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10954298A 1998-07-02 1998-07-02
PCT/US1999/013693 WO2000001671A2 (en) 1998-07-02 1999-06-17 Antihistaminic piperidine derivatives and intermediates for the preparation thereof

Publications (3)

Publication Number Publication Date
NO20006694D0 NO20006694D0 (no) 2000-12-29
NO20006694L true NO20006694L (no) 2001-03-01
NO319534B1 NO319534B1 (no) 2005-08-29

Family

ID=22328222

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006694A NO319534B1 (no) 1998-07-02 2000-12-29 Mellomprodukt og fremgangsmater for fremstilling av antihistaminiske piperidinderivater og anvendelse derav for fremstilling av et medikament.

Country Status (21)

Country Link
EP (1) EP1091938B1 (no)
JP (1) JP2002519411A (no)
KR (2) KR100707904B1 (no)
CN (3) CN100522921C (no)
AR (1) AR019197A1 (no)
AT (1) ATE485271T1 (no)
AU (1) AU769284B2 (no)
BR (1) BR9911794A (no)
CA (1) CA2336380C (no)
DE (1) DE69942876D1 (no)
DK (1) DK1091938T3 (no)
ES (1) ES2354968T3 (no)
HK (3) HK1034065A1 (no)
HU (1) HUP0104159A3 (no)
IL (6) IL140649A0 (no)
NO (1) NO319534B1 (no)
NZ (2) NZ528839A (no)
PT (1) PT1091938E (no)
TW (1) TW533197B (no)
WO (1) WO2000001671A2 (no)
ZA (1) ZA200007034B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003104197A1 (en) 2002-06-10 2003-12-18 Teva Pharmaceutical Industries Ltd. Polymorphic form xvi of fexofenadine hydrochloride
CN101585768B (zh) * 2009-06-06 2012-01-04 浙江大学宁波理工学院 合成2-[4-(4-氯丁酰基)苯基]-2-甲基丙酸酯的方法
CN101585767B (zh) * 2009-06-06 2012-02-15 浙江大学宁波理工学院 一种合成2—[4—(4—氯丁酰基)苯基]—2—甲基丙酸酯的方法
CN101585764B (zh) * 2009-06-06 2012-02-15 浙江大学宁波理工学院 合成2—［4—(4—氯丁酰基)苯基］—2—甲基丙酸的方法
CN101585763B (zh) * 2009-06-06 2012-01-04 浙江大学宁波理工学院 一种合成2-[4-(4-氯丁酰基)苯基]-2-甲基丙酸的方法
EP2289867A3 (en) * 2009-08-19 2012-04-25 Jubilant Organosys Limited A process for producing 4-(4-halo-1-oxybutyl)-alpha,alpha-dimethylbenzene acetic acid or alkyl esters thereof
JP6192554B2 (ja) * 2014-02-03 2017-09-06 三菱電機株式会社 真空断熱材の製造方法
CN112661693A (zh) * 2021-01-27 2021-04-16 西北农林科技大学 一种非索非那定的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3839431A (en) * 1970-07-13 1974-10-01 Squibb & Sons Inc Cyclopropylmethylphenylacetic acids and derivatives
US4254129A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
MX9302076A (es) * 1992-04-10 1994-03-31 Merrell Dow Pharma Proceso novedoso para preparar derivados de piperidina.
US5654433A (en) * 1993-01-26 1997-08-05 Merrell Pharmaceuticals Inc. Process for piperidine derivatives
WO1995000482A1 (en) * 1993-06-24 1995-01-05 Albany Molecular Research, Inc. Piperidine derivatives and process for their production
CN1159277C (zh) * 1993-06-25 2004-07-28 默里尔药物公司 用于制备抗组胺哌啶衍生物的新中间体
KR19990008406A (ko) * 1995-05-08 1999-01-25 스티븐엘.네스비트 알파-(치환된 알킬페닐)-4-(히드록시디페닐메틸)-1-피페리딘 부탄올 유도체들, 그들의 제조 방법 및 항히스타민제, 항알러지제및 기관지 확장제로서 그들의 용도

Also Published As

Publication number Publication date
BR9911794A (pt) 2001-03-27
NO319534B1 (no) 2005-08-29
ATE485271T1 (de) 2010-11-15
IL140649A (en) 2006-08-01
CN101311165A (zh) 2008-11-26
CN101311165B (zh) 2011-05-18
DK1091938T3 (da) 2011-02-07
EP1091938A2 (en) 2001-04-18
HUP0104159A2 (hu) 2002-03-28
IL171063A (en) 2007-09-20
IL171061A (en) 2007-09-20
HK1091806A1 (en) 2007-01-26
JP2002519411A (ja) 2002-07-02
AR019197A1 (es) 2001-12-26
CN1308611A (zh) 2001-08-15
ZA200007034B (en) 2002-04-08
ES2354968T3 (es) 2011-03-21
HUP0104159A3 (en) 2002-04-29
EP1091938B1 (en) 2010-10-20
DE69942876D1 (de) 2010-12-02
KR100707904B1 (ko) 2007-04-16
IL171062A (en) 2007-09-20
NO20006694D0 (no) 2000-12-29
AU4574699A (en) 2000-01-24
IL140649A0 (en) 2002-02-10
CN100522921C (zh) 2009-08-05
AU769284B2 (en) 2004-01-22
KR20060035816A (ko) 2006-04-26
CA2336380C (en) 2007-04-10
HK1034065A1 (en) 2001-10-12
CA2336380A1 (en) 2000-01-13
CN1246312C (zh) 2006-03-22
CN1807394A (zh) 2006-07-26
IL171479A (en) 2007-10-31
KR100682447B1 (ko) 2007-02-16
NZ528839A (en) 2005-03-24
HK1125382A1 (en) 2009-08-07
WO2000001671A3 (en) 2000-04-06
WO2000001671A2 (en) 2000-01-13
NZ508477A (en) 2003-12-19
TW533197B (en) 2003-05-21
KR20010053324A (ko) 2001-06-25
PT1091938E (pt) 2010-12-20

Similar Documents

Publication Publication Date Title
NO980720D0 (no) Pyridazin-3-on-derivater, deres anvendelse og mellomprodukter for deres fremstilling
NO20022289L (no) Ny anvendelse og nye N-azabisykloamidderivater
DK1084102T3 (da) Nye 3-arylpropionsyrederivater og analoge
NO983356D0 (no) Nye 19-nor-pregnenderivater
DK1454907T3 (da) Quninazolin og pyridopyrmidin-derivativer
NO20005832D0 (no) Nye spesielle formuleringer
DK199900904A (da) Nye O-acyloxim-fotoinitiatorer
NO20015547D0 (no) Halvsyntetisk fremgangsmåte og nye forbindelser
NO992400D0 (no) Nye substituerte pyrazolderivater
NO20005266L (no) Nye substituerte amider, deres fremstilling og anvendelse
NO20003346L (no) Nye erytromycinderivater
NO20011157L (no) Benzenderivater og farmasöytisk anvendelse derav
DK1237857T3 (da) Nye Phenalkyloxyphenylderivater
NO20003070D0 (no) Substituert tiazolidinderivat, fremgangsmÕte for fremstilling og anvendelse derav
PT1246816E (pt) Derivados de fenilpiperazina substituidos sua preparacao e utilizacao
NO20003916D0 (no) Benzotiadiazoler og derivater
NO20003965D0 (no) Nye dihydroksyheksansyre-derivater
NO20010860D0 (no) Nye forbindelser
NO20010861D0 (no) Nye forbindelser
NO960268D0 (no) Nye dialkoksypyridinylbenzimidazolderivater
IS4980A (is) Aðferðir og milliefni við framleiðslu á setnum krómanól afleiðum
NO20006694D0 (no) Nye antihistamin-piperidinderivater og mellomprodukter for fremstilling derav
NO20025968D0 (no) Pyridin-2-yl-aminoalkylkarbonylglycyl-<beta>-alanin og derivater derav
DK0931087T3 (da) Nye pyranosidderivater
DK0983249T3 (da) Fremgangsmåder og mellemprodukter til fremstilling af substituerede indazolderivater

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: AVENTISUB LLC, US

MM1K Lapsed by not paying the annual fees